{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:30:27Z","timestamp":1794875427334,"version":"4.9.1"},"reference-count":18,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T00:00:00Z","timestamp":1718150400000},"content-version":"unspecified","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["16\/137\/44"],"award-info":[{"award-number":["16\/137\/44"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Surg Interv Health Technologies"],"accepted":{"date-parts":[[2024,3,28]]},"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>The Global IDEAL Sub-Framework Study aimed to combine the intended effects of the 2009\/2019 IDEAL (Idea, Development, Exploration, Assessment, Long-term study) Framework recommendations on evaluating surgical innovation with the vision outlined by the 2015 Lancet Commission on Global Surgery to provide recommendations for evaluating surgical innovation in low-resource environments.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A mixture of methods including an online global survey and semistructured interviews (SSIs). Quantitative data were summarized with descriptive statistics and qualitative data were analyzed using the Framework Method.<\/jats:p><\/jats:sec><jats:sec><jats:title>Participants<\/jats:title><jats:p>Surgeons and surgical researchers from any country.<\/jats:p><\/jats:sec><jats:sec><jats:title>Main outcome measures<\/jats:title><jats:p>Findings were used to suggest the nature of adaptations to the IDEAL Framework to address the particular problems of evaluation in low-resource settings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The online survey yielded 66 responses representing experience from 40 countries, and nine individual SSIs were conducted. Most respondents (n=49; 74.2%) had experience evaluating surgical technologies across a range of life cycle stages. Innovation was most frequently adopted based on colleague recommendation or clinical evaluation in other countries. Four themes emerged, centered around: frugal innovation in technological development; evaluating the same technology\/innovation in different contexts; additional methodologies important in evaluation of surgical innovation in low\/middle-income countries; and support for low-income country researchers along the evaluation pathway.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The Global IDEAL Sub-Framework provides suggestions for modified IDEAL recommendations aimed at dealing with the special problems found in this setting. These will require validation in a stakeholder consensus forum, and qualitative assessment in pilot studies. From assisting researchers with identification of the correct evaluation stage, to providing context-specific recommendations relevant to the whole evaluation pathway, this process will aim to develop a comprehensive and applicable set of guidance that will benefit surgical innovation and patients globally.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjsit-2023-000248","type":"journal-article","created":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T23:05:26Z","timestamp":1718233526000},"page":"e000248","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["No frugal innovation without frugal evaluation: the Global IDEAL Sub-Framework"],"prefix":"10.1136","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8451-9595","authenticated-orcid":false,"given":"William S","family":"Bolton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel K","family":"Aruparayil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Cundill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3210-8273","authenticated-orcid":false,"given":"Peter","family":"McCulloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7444-5892","authenticated-orcid":false,"given":"Jesudian","family":"Gnanaraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Bundu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R","family":"Culmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia M","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G","family":"Jayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,6,12]]},"reference":[{"key":"2024061216052132000_6.1.e000248.1","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.11036"},{"key":"2024061216052132000_6.1.e000248.2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002794"},{"key":"2024061216052132000_6.1.e000248.3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61116-8"},{"key":"2024061216052132000_6.1.e000248.4","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i2372","article-title":"IDEAL-D: a rational framework for evaluating and regulating the use of medical devices","volume":"2372","author":"Sedrakyan","year":"2016","journal-title":"BMJ"},{"key":"2024061216052132000_6.1.e000248.5","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijsu.2018.07.008","article-title":"Appraising the uptake and use of the IDEAL framework and recommendations: a review of the literature","volume":"57","author":"Khachane","year":"2018","journal-title":"Int J Surg"},{"key":"2024061216052132000_6.1.e000248.6","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60160-X"},{"key":"2024061216052132000_6.1.e000248.7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61455-5"},{"key":"2024061216052132000_6.1.e000248.8","doi-asserted-by":"crossref","DOI":"10.1186\/s12939-018-0748-6","article-title":"Barriers for conducting clinical trials in developing Countries- a systematic review","volume":"17","author":"Alemayehu","year":"2018","journal-title":"Int J Equity Health"},{"key":"2024061216052132000_6.1.e000248.9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2288-13-1"},{"key":"2024061216052132000_6.1.e000248.10","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000000388"},{"key":"2024061216052132000_6.1.e000248.11","doi-asserted-by":"publisher","DOI":"10.1016\/j.evalprogplan.2004.09.002"},{"key":"2024061216052132000_6.1.e000248.12","unstructured":"Rowher A , Booth A , Pfadenhauer L , et al . Guidance on the use of logic models in health technology assessments of complex interventions. Int J Technol Assess Health Care 2016."},{"key":"2024061216052132000_6.1.e000248.13","unstructured":"Radjou N , Prabhu J , Ahuja S . Jugaad Innovation: Think Frugal, Be Flexible, Generate Breakthrough Growth. John Wiley & Sons, 2012."},{"key":"2024061216052132000_6.1.e000248.14","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61127-1"},{"key":"2024061216052132000_6.1.e000248.15","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-002269","article-title":"Using implementation science theories and frameworks in global health","volume":"5","author":"Ridde","year":"2020","journal-title":"BMJ Glob Health"},{"key":"2024061216052132000_6.1.e000248.16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/SLA.0000000000005053","article-title":"Beyond the RCT: when are randomised trials unnecessary for new therapeutic devices, and what should we do instead","volume":"275","author":"P\u00e1ez","year":"2022","journal-title":"Ann Surg"},{"key":"2024061216052132000_6.1.e000248.17","doi-asserted-by":"crossref","unstructured":"van der Graaf R , Cheah PY . Ethics of alternative trial designs and methods in low-resource settings. Trials 2019;20. doi:10.1186\/s13063-019-3841-2","DOI":"10.1186\/s13063-019-3841-2"},{"key":"2024061216052132000_6.1.e000248.18","doi-asserted-by":"crossref","first-page":"e691","DOI":"10.1016\/S2214-109X(20)30540-4","article-title":"Randomised trials at the level of the individual","volume":"9","author":"Park","year":"2021","journal-title":"Lancet Glob Health"}],"container-title":["BMJ Surgery, Interventions, &amp; Health Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjsit-2023-000248","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T23:05:34Z","timestamp":1718233534000},"score":1,"resource":{"primary":{"URL":"https:\/\/sit.bmj.com\/lookup\/doi\/10.1136\/bmjsit-2023-000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":18,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,6,12]]},"published-print":{"date-parts":[[2024,6]]}},"alternative-id":["10.1136\/bmjsit-2023-000248"],"URL":"https:\/\/doi.org\/10.1136\/bmjsit-2023-000248","relation":{},"ISSN":["2631-4940"],"issn-type":[{"value":"2631-4940","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6]]}}}